Transition report pursuant to Rule 13a-10 or 15d-10

Revisions of Financial Statements for the six months ending December 31, 2020 and 2019 (Tables)

v3.21.1
Revisions of Financial Statements for the six months ending December 31, 2020 and 2019 (Tables)
6 Months Ended
Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of reclassifications



Three Months Ended December 31, 2019


As reported

Adjustment


As revised
Condensed Consolidated Statements of Operations









Cost of revenue


1,638,840

(23,601 )
1,615,239
Gross profit

1,667,363

23,601

1,690,964
Product development 

1,261,509

(638,008 )
623,501
Selling, general and administrative

4,796,404

86,768

4,883,172
Net loss

(4,338,536 )
574,841

(3,763,695 )
Net loss per share

(0.40 )


(0.34 )













Six Months Ended December 31, 2019



As reported Adjustment As revised
Condensed Consolidated Statements of Operations









Cost of revenue

 

 

3,036,201
(41,261 )
2,994,940
Gross profit

 


3,462,892

41,261

3,504,153
Product development

2,392,389
(1,157,986 )
1,234,403
Selling, general and administrative

 


8,380,219
104,667
8,484,886
Net loss

(7,184,607 )
1,094,580

(6,090,027 )
Net loss per share

(0.66 )


(0.56 )

 

 











Three Months Ended March 31, 2020


As reported

Adjustment


As revised
Condensed Consolidated Statements of Operations 









Cost of revenue


1,420,909

(24,690 )
1,396,219
Gross profit

1,649,637

24,690

1,674,327
Product development 

1,632,353

(757,566 )
874,787
Selling, general and administrative

5,500,837

177,405

5,678,242
Net loss

(5,348,980 )
604,851

(4,744,129 )
Net loss per share

(0.43 )


(0.38 )